ESH Workshop LEUKEMIC AND CANCER STEM CELLS

Information

Objectives: The identification of cancer stem cells (CSC) in most cancers has led to the emergence of a new field in cancer research that is expected to provide insight into oncogenesis and hope for improved survival and cure. Evidence of CSC first arose in the field of hematology through the study of leukemia. Although a number of isolation techniques have been developed and a large body of data on leukemic stem cells (LSC) and Cancer Initiating Cells in solid tumors have accumulated, they have proved difficult to isolate and amplify. This prompts hematologists to address the issue of the identification of novel markers with caution.

This ESH workshop aims to support the development of LSC networks in Europe. Since the first meeting in 2009, attended by more than 150 participants from over 26 countries, two networks have emerged from the group: the EHA Scientific Workgroup on Cancer and Leukemic Stem Cells and the EuroCSCTraining Network (7th People PCRD-Marie Curie) for young researchers.

Targeted audience: Researchers already in the field (or wishing to enter it), clinicians involved in novel targeted therapies, young researchers and biologists working in hematology or cancer research or hospital laboratories. Private companies involved in cancer stem cell identification or targeting.